Immediate Impact
1 by Nobel laureates 2 from Science/Nature 59 standout
Citing Papers
A Phase 2 Randomized Trial of Survodutide in MASH and Fibrosis
2024 Standout
Randomized, Controlled Trial of the FGF21 Analogue Pegozafermin in NASH
2023 Standout
Works of K. G. Stanton being referenced
Benefits and Safety of Long-Term Fenofibrate Therapy in People With Type 2 Diabetes and Renal Impairment
2011
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| K. G. Stanton | 368 | 154 | 308 | 261 | 25 | 952 | |
| D Santoro | 376 | 155 | 424 | 389 | 23 | 990 | |
| Fotios Iliadis | 261 | 123 | 212 | 294 | 30 | 912 | |
| Marco Righetti | 414 | 117 | 358 | 169 | 34 | 1.1k | |
| Fiona C. Ballantyne | 310 | 217 | 150 | 107 | 38 | 746 | |
| Dan Streja | 371 | 186 | 138 | 192 | 32 | 772 | |
| H. J. G. Bilo | 391 | 162 | 213 | 193 | 43 | 970 | |
| E. Kearney | 185 | 138 | 201 | 279 | 28 | 778 | |
| Jobien K. Olijhoek | 338 | 322 | 532 | 172 | 21 | 1.1k | |
| Henry Krum | 161 | 158 | 733 | 146 | 34 | 1.2k | |
| Nikolaos Ioakeimidis | 353 | 160 | 476 | 189 | 34 | 1.2k |
All Works
Loading papers...